Mirum Pharmaceuticals (MIRM) EBT Margin: 2020-2025
Historic EBT Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Sep 2025 value amounting to 1.99%.
- Mirum Pharmaceuticals' EBT Margin rose 1735.00% to 1.99% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.65%, marking a year-over-year increase of 2326.00%. This contributed to the annual value of -25.80% for FY2024, which is 6135.00% up from last year.
- According to the latest figures from Q3 2025, Mirum Pharmaceuticals' EBT Margin is 1.99%, which was up 146.51% from -4.27% recorded in Q2 2025.
- Mirum Pharmaceuticals' EBT Margin's 5-year high stood at 1,825.75% during Q4 2021, with a 5-year trough of -941.98% in Q3 2021.
- In the last 3 years, Mirum Pharmaceuticals' EBT Margin had a median value of -30.82% in 2024 and averaged -46.55%.
- In the last 5 years, Mirum Pharmaceuticals' EBT Margin plummeted by 931,097bps in 2021 and then skyrocketed by 75,192bps in 2022.
- Over the past 5 years, Mirum Pharmaceuticals' EBT Margin (Quarterly) stood at 1,825.75% in 2021, then slumped by 195,580bps to -130.05% in 2022, then surged by 7,910bps to -50.94% in 2023, then spiked by 2,643bps to -24.51% in 2024, then skyrocketed by 1,735bps to 1.99% in 2025.
- Its EBT Margin was 1.99% in Q3 2025, compared to -4.27% in Q2 2025 and -12.23% in Q1 2025.